RA0472

antibody from Oursmab

Targeting: LYPD3 C4.4A

Western blot (Supportive data in Antibodypedia)

ELISA (Supportive data in Antibodypedia)

Immunocytochemistry (Recommended by provider)

Flow cytometry (Recommended by provider)

Functional assay (Recommended by provider)

Antibody Data

Product number

RA0472

Provider

Oursmab

Product name

Lupartumab (Biosimilar Reference Antibody) (LYPD3)

Antibody type

Monoclonal

Description

Lupartumab is a human IgG1-lambda2 monoclonal antibody that specifically targets LYPD3 (also known as C4.4A), a glycosylphosphatidylinositol (GPI)-anchored cell-surface protein. As an IgG1 isotype, it is engineered to engage immune effector functions such as antibody-dependent cellular cytotoxicity (ADCC).

Reactivity

Human

Isotype

IgG

Vial size

100 ¦Ìg,1 mg,5 mg,10 mg,25 mg,50 mg,100 mg

Concentration

Bottled at the concentration indicated on the vial.

Storage

Store at -20¡ãC or -80¡ãC. Avoid repeated freeze.

Western blot

Supportive validation

Submitted by

Oursmab (provider)

Main image

Experimental details

Lupartumab (Biosimilar Reference Antibody) (LYPD3)-RA0472-Oursmab determined by SDS-PAGE. The purity of the protein is greater than 98%.

ELISA

Supportive validation

Submitted by

Oursmab (provider)

Main image

Experimental details

ELISA plate pre-coated Antigen protein, can bind Lupartumab (Biosimilar Reference Antibody) (LYPD3)-RA0472 in a linear range of 0.18¨C15 ng/mL.